Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-07-30
1999-12-14
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
060018577
ABSTRACT:
4-Heterocyclyl-substituted dihydropyridines are prepared by reacting appropriate aldehydes with .beta.-keto esters and aminocrotonic acid esters, or by esterifying 4-heterocyclyl-substituted dihydropyridinecarboxylic acids. The 4-heterocyclyl-substituted dihydropyridines can be employed in medicaments, in particular for the treatment of disorders of the central nervous system.
REFERENCES:
patent: 3488359 (1970-01-01), Bossert et al.
patent: 3574843 (1971-04-01), Bossert et al.
patent: 4021434 (1977-05-01), Murakami et al.
patent: 4406906 (1983-09-01), Meyer et al.
patent: 4510310 (1985-04-01), Wehinger et al.
patent: 4568681 (1986-02-01), Wehinger et al.
patent: 4622332 (1986-11-01), Wehinger et al.
patent: 4672068 (1987-06-01), Kutsuma et al.
patent: 4727066 (1988-02-01), Sunkel et al.
patent: 4849433 (1989-07-01), Wehinger et al.
patent: 4988717 (1991-01-01), Wehinger et al.
CA 103:178176, Kuehnis et al, 1985.
CA 109:190251x, Bky-Gulden, 1988.
Principles of Psychopharmacology, Clark et al. Academic Press, pp. 166-167, 1970.
Current Neurology vol. 6 Appel, pp. 289, 314-315, Year Book Medical Publishers, Inc., 1987.
Dihydropyridines--Progress in Pharmacology and Therapy (W.D. Bruse B. Garthoff F. Seuter (Eds.) 1993.
Diagnosis and Treatment of Senile Dementia (M. Bergener B. Reisberg (eds.) 1993.
Some Behavioral Effects of Repeated Administration of Calcium Channel Antagonists (Pharmacology Biochemistry & Behavior, vol. 35, pp. 557-560).
The FASEB Journal, vol. 3. (May 19890--Scriabine et al.
J. Heterocyclic Chem., Bd 25, Nr. 1, 1988, Seiten 81-87 Directed Lithiation of 4-halopyridines.
Eur. J. Med. Chem.--Chim. Ther., Bd. 18, Nr. 2, 1983, pp. 155-161.
J. Heterocycles, vol. 107, 1987, pp. 723.
J. Heterocycles, vol. 108, 1988--108:55919k--Chemical Abstract.
J. Heterocycles, vol. 111, 1989--111:2355u--Chemical Abstract.
Heterocycles, vol. 83, 1975,--28058n--Chemical Abstract.
Rampe, et al "Comparative aspects and temperature dependence of . . . " Sep. 8, 1986, pp. 1452-1460.
Derwent Abstract JP-239353 Aug. 30, 1988.
Trends Pharmacol. Sci. Bd. 11, Nr. 8, 1990, pp. 309-310, "Nimodipine and the recovery of memory".
Patent Abstracts of Japan, vol. 015, No. 425, (C-0879)29. Oct. 1991, & JP-A-31 76 471 (Sawai Seiyaku KK) Dec. 5., 1989.
Cupka et al., CA 108:5844M, 1988.
Vanden et al., CA 116:151512h, 1992.
Eynde et al., CA 116:194103t, 1992.
Yoshinaga, et al., CA 115:256001y, 1991.
Kusuma et al., CA 104:207168x, 1986.
de Jonge Maarten
Gao Zhan
Hartwig Wolfgang
Junge Bodo
Meier Heinrich
Bayer Aktiengesellschaft
Fan Jane
LandOfFree
Heterocyclyl substituted dihydropyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclyl substituted dihydropyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclyl substituted dihydropyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863812